FDA Accepts First AI Drug Development Tool for Liver Toxicity Prediction
The US FDA has accepted the first Letter of Intent for an AI-driven drug development tool, a Digital Liver Model designed to predict liver toxicity.…
Read moreDesk archive
The US FDA has accepted the first Letter of Intent for an AI-driven drug development tool, a Digital Liver Model designed to predict liver toxicity.…
Read more
The US FDA has introduced a real-time clinical trial model to monitor safety during trials, partnering with major institutions and pharmaceutical companies. This development signals…
Read more